Önal Ceren, Saraçoğlu Kemal Tolga, Saraçoğlu Ayten, Özkan Beyza Nur, Güler Eray Metin, Arslan Gülten, Karakuş Seçil Azime, Bulun Yekbun, Gaszynski Tomasz, Ratajczyk Pawel
Department of Anesthesiology and Reanimation, Ağrı Research and Training Hospital, Ağrı 04200, Türkiye.
Department of Anaesthesiology, ICU & Perioperative Medicine, Hazm Mebaireek General Hospital HMC, Qatar University College of Medicine, Doha P.O. Box 2713, Qatar.
Biomedicines. 2024 Jul 24;12(8):1652. doi: 10.3390/biomedicines12081652.
The primary objective of this in vitro study was to prevent the risk of toxicity associated with bupivacaine, widely used in clinical practice, by using magnesium (Mg), a readily available and cost-effective element, as an adjuvant. We hypothesized that Mg might exhibit a protective effect against cytotoxicity in a colon cell culture model under conditions of bupivacaine-induced LAST. Our secondary aim was to investigate its effect on genotoxicity, apoptosis, and iROS. CCD-18Co cells were used in our study. Control group (group C), Bupivacaine group (group B), Magnesium group (group M), and Bupivacaine+Mg group (group BM) were created. The viability of CCD-18Co cells incubated for 24 h in group C was determined to be 100%. These cells were evenly divided, and bupivacaine was administered to group B at concentrations of 5 to 300 μM. In group M, doses of Mg at 0.625 to 320 mEq were added. It was determined that the maximum viability was observed at a Mg dose of 40 mEq ( < 0.05). In group BM, bupivacaine was administered at the same concentrations in combination with Mg (40 mEq), and cell viability was measured. DNA damage, apoptosis, and iROS were assessed at concentrations of bupivacaine by administering 40 mEq Mg. In group B, viability decreased dose-dependently in CCD-18Co ( < 0.05, < 0.01, < 0.001). In group BM, the viability decreased in cells at increasing concentrations compared to group C ( < 0.05, < 0.01, < 0.001), but the viability was affected positively compared to group B ( < 0.05). In group B, DNA damage increased ( < 0.05, < 0.001). In group BM, DNA damage increased ( < 0.05, < 0.001). However, in group BM, DNA damage levels were reduced compared to group B ( < 0.05, < 0.01). In group B, apoptosis increased ( < 0.05, < 0.001); in group BM, apoptosis increased ( < 0.001) compared to group C. However, in group BM, apoptosis decreased compared to group B (< 0.05). iROS increased in group B ( < 0.05, < 0.01, < 0.01) and group BM ( < 0.05, < 0.01, < 0.001) compared to the group C. However, in group BM, iROS decreased in comparison to group B ( < 0.05). In conclusion, Mg exhibits a protective effect against bupivacaine-induced toxicity.
本体外研究的主要目的是,通过使用镁(Mg)这种易于获取且经济高效的元素作为佐剂,来预防临床实践中广泛使用的布比卡因相关的毒性风险。我们假设,在布比卡因诱导的局部麻醉中毒综合征(LAST)条件下,镁可能在结肠细胞培养模型中对细胞毒性表现出保护作用。我们的次要目的是研究其对遗传毒性、细胞凋亡和细胞内活性氧(iROS)的影响。我们的研究使用了CCD - 18Co细胞。设立了对照组(C组)、布比卡因组(B组)、镁组(M组)和布比卡因 + 镁组(BM组)。C组中培养24小时的CCD - 18Co细胞活力测定为100%。将这些细胞均匀分开,以5至300 μM的浓度给B组施用布比卡因。在M组中,添加0.625至320 mEq的镁剂量。结果确定在40 mEq的镁剂量下观察到最大活力(P < 0.05)。在BM组中,以相同浓度联合40 mEq的镁施用布比卡因,并测量细胞活力。通过施用40 mEq的镁,在布比卡因浓度下评估DNA损伤、细胞凋亡和iROS。在B组中,CCD - 18Co细胞的活力呈剂量依赖性下降(P < 0.05,P < 0.01,P < 0.001)。在BM组中,与C组相比,细胞活力随浓度增加而下降(P < 0.05,P < 0.01,P < 0.001),但与B组相比,活力受到了积极影响(P < 0.05)。在B组中,DNA损伤增加(P < 0.05,P < 0.001)。在BM组中,DNA损伤也增加(P < 0.05,P < 0.001)。然而,在BM组中,DNA损伤水平与B组相比有所降低(P < 0.05,P < 0.